XSS Vulnerability in Unknown Web Application via Hostname Parameter
CVE-2023-40153 Published on October 19, 2023

Cross-site Scripting in DEXMA DEXGate
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

NVD

Vulnerability Analysis

CVE-2023-40153 can be exploited with network access, and requires small amount of user privileges. This vulnerability is considered to have a low attack complexity. The potential impact of an exploit of this vulnerability is considered to have a small impact on confidentiality and integrity, and no impact on availability.

Attack Vector:
NETWORK
Attack Complexity:
LOW
Privileges Required:
LOW
User Interaction:
NONE
Scope:
UNCHANGED
Confidentiality Impact:
LOW
Integrity Impact:
LOW
Availability Impact:
NONE

Weakness Type

What is a XSS Vulnerability?

The software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

CVE-2023-40153 has been classified to as a XSS vulnerability or weakness.


Products Associated with CVE-2023-40153

Want to know whenever a new CVE is published for Dexma Dexgate? stack.watch will email you.

Dexma Dexgate
 

Affected Versions

DEXMA DexGate Version 20130114 is affected by CVE-2023-40153

Exploit Probability

EPSS
0.26%
Percentile
49.49%

EPSS (Exploit Prediction Scoring System) scores estimate the probability that a vulnerability will be exploited in the wild within the next 30 days. The percentile shows you how this score compares to all other vulnerabilities.